Vertex Pharmaceuticals Incorporated shares owned by Achmea Investment Management B.V.
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Achmea Investment Management B.V.
from 13F filings
Historical chart of Achmea Investment Management B.V. investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Achmea Investment Management B.V. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Achmea Investment Management B.V.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $7.4M | 16k | 465.11 |
| 2024-06-30 | $17M | 37k | 468.71 |
| 2024-03-31 | $21M | 50k | 418.00 |
| 2023-12-31 | $19M | 48k | 406.89 |
| 2023-09-30 | $20M | 56k | 347.74 |
| 2023-06-30 | $20M | 56k | 351.92 |
| 2023-03-31 | $16M | 50k | 315.08 |
| 2022-12-31 | $14M | 51k | 270.58 |
| 2022-09-30 | $15M | 50k | 289.55 |
| 2022-06-30 | $11M | 38k | 281.79 |
| 2022-03-31 | $9.4M | 36k | 260.99 |
| 2021-09-30 | $6.9M | 38k | 181.41 |
| 2021-06-30 | $8.3M | 41k | 201.62 |
| 2021-03-31 | $3.4M | 16k | 214.89 |
| 2020-12-31 | $3.8M | 16k | 236.35 |
| 2020-09-30 | $4.3M | 16k | 272.12 |
| 2020-06-30 | $11M | 38k | 290.30 |
| 2019-12-31 | $3.2M | 15k | 218.95 |
| 2019-09-30 | $2.5M | 15k | 169.39 |
| 2019-06-30 | $2.7M | 15k | 183.38 |
| 2019-03-31 | $2.8M | 15k | 183.93 |
| 2018-12-31 | $2.5M | 15k | 165.72 |
| 2018-09-30 | $2.8M | 14k | 192.68 |
| 2018-06-30 | $2.9M | 17k | 169.94 |
| 2018-03-31 | $2.8M | 17k | 162.98 |
| 2017-12-31 | $2.5M | 17k | 149.85 |
| 2017-09-30 | $1.7M | 12k | 151.82 |
| 2017-06-30 | $1.1M | 8.7k | 128.69 |
| 2017-03-31 | $564k | 5.2k | 109.28 |
More positions owned by Achmea Investment Management B.V.
View all positions for Achmea Investment Management B.V.
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated